{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:22:58Z","timestamp":1792801378729,"version":"4.5.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T00:00:00Z","timestamp":1574467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA208648"],"award-info":[{"award-number":["R01 CA208648"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.redox.2019.101394","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T20:25:07Z","timestamp":1574713507000},"page":"101394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":285,"special_numbering":"C","title":["Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree?"],"prefix":"10.1016","volume":"29","author":[{"given":"Balaraman","family":"Kalyanaraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2019.101394_bib1","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2014.06.1175","article-title":"Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement","volume":"64","author":"Rosen","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.redox.2019.101394_bib2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jacbts.2016.05.008","article-title":"21st century cardio-oncology: identifying cardiac safety signals in the era of personalized medicine","volume":"1","author":"Sheng","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.redox.2019.101394_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/HCO.0000000000000617","article-title":"Adriamycin-associated cardiomyopathy: where are we now? updates in pathophysiology, dose recommendations, prognosis, and outcomes","volume":"34","author":"Hardaway","year":"2019","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.redox.2019.101394_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJM198107163050305","article-title":"The anthracycline antineoplastic drugs","volume":"305","author":"Young","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2019.101394_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-80-2-249","article-title":"Adriamycin. A new anticancer drug with significant clinical activity","volume":"80","author":"Blum","year":"1974","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.redox.2019.101394_bib6","first-page":"873","article-title":"Clinical spectrum of anthracycline antibiotic cardiotoxicity","volume":"62","author":"Bristow","year":"1978","journal-title":"Cancer Treat Rep."},{"key":"10.1016\/j.redox.2019.101394_bib7","first-page":"198","article-title":"Adriamycin (NSC 123127) Cardiomyopathy: an overview with determination of risk factors","volume":"6","author":"M","year":"1975","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/j.redox.2019.101394_bib8","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJM199809243391307","article-title":"Doxorubicin-induced cardiomyopathy","volume":"339","author":"Singal","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2019.101394_bib9","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1200\/JCO.2005.02.5841","article-title":"Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study","volume":"23","author":"Doyle","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.redox.2019.101394_bib10","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/cncr.11274","article-title":"Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study","volume":"97","author":"Sorensen","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.redox.2019.101394_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00148581-200507020-00001","article-title":"Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management","volume":"7","author":"Iarussi","year":"2005","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.redox.2019.101394_bib12","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1200\/JCO.2005.12.121","article-title":"Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia","volume":"23","author":"Lipshultz","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.redox.2019.101394_bib13","first-page":"893","volume":"vol 12","author":"Benson","year":"2016"},{"key":"10.1016\/j.redox.2019.101394_bib14","first-page":"1365","volume":"vol 13","author":"Benson","year":"2017"},{"key":"10.1016\/j.redox.2019.101394_bib15","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41401-018-0062-2","article-title":"Cancer immune checkpoint blockade therapy and its associated autoimmune cardiotoxicity","volume":"39","author":"Zhang","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.redox.2019.101394_bib16","first-page":"523","article-title":"Stimulation of microsomal NADPH oxidation by quinone group-containing anticancer chemicals","volume":"67","author":"Handa","year":"1976","journal-title":"Gan"},{"key":"10.1016\/j.redox.2019.101394_bib17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0026-895X(25)12453-X","article-title":"Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation","volume":"13","author":"Bachur","year":"1977","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.redox.2019.101394_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0003-9861(81)90263-0","article-title":"Pulse radiolysis studies of antitumor quinones: radical lifetimes, reactivity with oxygen, and one-electron reduction potentials","volume":"209","author":"Svingen","year":"1981","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.redox.2019.101394_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1126\/science.877547","article-title":"Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response","volume":"197","author":"Myers","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.redox.2019.101394_bib20","first-page":"2792","article-title":"Role of iron in adriamycin biochemistry","volume":"45","author":"Myers","year":"1986","journal-title":"Fed. Proc."},{"key":"10.1016\/j.redox.2019.101394_bib21","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/S0021-9258(17)35746-0","article-title":"Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase","volume":"261","author":"Davies","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101394_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1096\/fasebj.13.2.199","article-title":"Role of iron in anthracycline cardiotoxicity: new tunes for an old song?","volume":"13","author":"Minotti","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.redox.2019.101394_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0304-4165(80)90142-7","article-title":"Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs","volume":"630","author":"Kalyanaraman","year":"1980","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2019.101394_bib24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0006-291X(77)80048-X","article-title":"Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin","volume":"77","author":"Goodman","year":"1977","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2019.101394_bib25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0003-9861(83)90572-6","article-title":"Kinetics of anthracycline antibiotic free radical formation and reductive glycosidase activity","volume":"223","author":"Gutierrez","year":"1983","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.redox.2019.101394_bib26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0304-4165(84)90270-8","article-title":"An electron spin resonance study of the reduction of peroxides by anthracycline semiquinones","volume":"799","author":"Kalyanaraman","year":"1984","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2019.101394_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-5793(82)81222-2","article-title":"Deoxyribose breakdown by the adriamycin semiquinone and H2O2: evidence for hydroxyl radical participation","volume":"145","author":"Bates","year":"1982","journal-title":"FEBS Lett."},{"key":"10.1016\/j.redox.2019.101394_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0003-9861(91)90023-C","article-title":"An electron paramagnetic resonance study of the interactions between the adriamycin semiquinone, hydrogen peroxide, iron-chelators, and radical scavengers","volume":"286","author":"Kalyanaraman","year":"1991","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.redox.2019.101394_bib29","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1021\/bi00537a001","article-title":"Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex","volume":"21","author":"Myers","year":"1982","journal-title":"Biochemistry"},{"key":"10.1016\/j.redox.2019.101394_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0014-5793(84)81130-8","article-title":"Hydroxyl radical production and DNA damage induced by anthracycline-iron complex","volume":"172","author":"Muindi","year":"1984","journal-title":"FEBS Lett."},{"key":"10.1016\/j.redox.2019.101394_bib31","doi-asserted-by":"crossref","first-page":"E5537","DOI":"10.1073\/pnas.1414665111","article-title":"Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling","volume":"111","author":"Dhingra","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2019.101394_bib32","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2019.101394_bib33","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/path.1863","article-title":"Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin","volume":"207","author":"Lebrecht","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.redox.2019.101394_bib34","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI118909","article-title":"The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice","volume":"98","author":"Yen","year":"1996","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.redox.2019.101394_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/phrs.2000.0769","article-title":"The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats","volume":"43","author":"Saad","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.redox.2019.101394_bib36","doi-asserted-by":"crossref","first-page":"33585","DOI":"10.1074\/jbc.M003890200","article-title":"Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species","volume":"275","author":"Kotamraju","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101394_bib37","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1200\/JCO.1997.15.4.1318","article-title":"Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer","volume":"15","author":"Swain","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.redox.2019.101394_bib38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1124\/jpet.117.244848","article-title":"Pharmacokinetics of the cardioprotective drug dexrazoxane and its active metabolite ADR-925 with focus on cardiomyocytes and the heart","volume":"364","author":"Jirkovsky","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.redox.2019.101394_bib39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12012-007-0023-3","article-title":"Dexrazoxane: how it works in cardiac and tumor cells. Is it a prodrug or is it a drug?","volume":"7","author":"Hasinoff","year":"2007","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.redox.2019.101394_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0929867305666220314194045","article-title":"Chemical, biological and clinical aspects of dexrazoxane and other bisdioxopiperazines","volume":"5","author":"Hasinoff","year":"1998","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.redox.2019.101394_bib41","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrclinonc.2013.195","article-title":"Treatment-related cardiotoxicity in survivors of childhood cancer","volume":"10","author":"Lipshultz","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.redox.2019.101394_bib42","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.bjp.0707294","article-title":"Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats","volume":"151","author":"Lebrecht","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2019.101394_bib43","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2217\/fca.12.44","article-title":"Cardiotoxicity in childhood cancer survivors: strategies for prevention and management","volume":"8","author":"Harake","year":"2012","journal-title":"Future Cardiol."},{"key":"10.1016\/j.redox.2019.101394_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070575","article-title":"Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical model","volume":"8","author":"Dickey","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2019.101394_bib45","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0891-5849(02)00989-9","article-title":"Paradoxical effects of metalloporphyrins on doxorubicin-induced apoptosis: scavenging of reactive oxygen species versus induction of heme oxygenase-1","volume":"33","author":"Konorev","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101394_bib46","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0167-7799(97)01068-8","article-title":"Selective targeting of bioactive compounds to mitochondria","volume":"15","author":"Murphy","year":"1997","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.redox.2019.101394_bib47","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1073\/pnas.0931245100","article-title":"Delivery of bioactive molecules to mitochondria in vivo","volume":"100","author":"Smith","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2019.101394_bib48","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.bpj.2008.10.042","article-title":"Doxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-Q","volume":"96","author":"Chandran","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.redox.2019.101394_bib49","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2019.101394_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012733","article-title":"Doxorubicin in vivo rapidly alters expression and translation of myocardial electron transport chain genes, leads to ATP loss and caspase 3 activation","volume":"5","author":"Pointon","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2019.101394_bib51","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.bbamcr.2016.01.021","article-title":"New signal transduction paradigms in anthracycline-induced cardiotoxicity","volume":"1863","author":"Ghigo","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2019.101394_bib52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bcp.2018.02.018","article-title":"Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction","volume":"150","author":"Sonowal","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2019.101394_bib53","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0008-6363(98)00009-1","article-title":"A small animal model of non-ischemic cardiomyopathy and its evaluation by transthoracic echocardiography","volume":"39","author":"Schwarz","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.redox.2019.101394_bib54","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ultrasmedbio.2007.07.018","article-title":"Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography","volume":"34","author":"Migrino","year":"2008","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.redox.2019.101394_bib55","doi-asserted-by":"crossref","first-page":"10363","DOI":"10.1074\/jbc.RA118.003044","article-title":"Detection of mitochondria-generated reactive oxygen species in cells using multiple probes and methods: potentials, pitfalls, and the future","volume":"293","author":"Cheng","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101394_bib56","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1161\/01.CIR.0000093196.59829.DF","article-title":"Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy","volume":"108","author":"Lebrecht","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2019.101394_bib57","first-page":"1072","article-title":"Mitochondrial cytochrome c oxidase as a target site for daunomycin in K-562 cells and heart tissue","volume":"53","author":"Papadopoulou","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2019.101394_bib58","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.redox.2017.12.012","article-title":"Teaching the basics of reactive oxygen species and their relevance to cancer biology: mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies","volume":"15","author":"Kalyanaraman","year":"2018","journal-title":"Redox Biology"},{"key":"10.1016\/j.redox.2019.101394_bib59","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jacbts.2018.02.003","article-title":"In vivo reactive oxygen species detection with a novel positron emission tomography tracer, (18)F-DHMT, allows for early detection of anthracycline-induced cardiotoxicity in rodents","volume":"3","author":"Boutagy","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.redox.2019.101394_bib60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40495-016-0063-0","article-title":"A critical review of methodologies to detect reactive oxygen and nitrogen species stimulated by NADPH oxidase enzymes: implications in pesticide toxicity","volume":"2","author":"Kalyanaraman","year":"2016","journal-title":"Curr Pharmacol Rep"},{"key":"10.1016\/j.redox.2019.101394_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2017.09.012","article-title":"Investigation of novel dexrazoxane analogue JR-311 shows significant cardioprotective effects through topoisomerase IIbeta but not its iron chelating metabolite","volume":"392","author":"Bures","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.redox.2019.101394_bib62","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1124\/mol.64.3.670","article-title":"The metabolites of the cardioprotective drug dexrazoxane do not protect myocytes from doxorubicin-induced cytotoxicity","volume":"64","author":"Hasinoff","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.redox.2019.101394_bib63","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI72931","article-title":"Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation","volume":"124","author":"Ichikawa","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.redox.2019.101394_bib64","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1158\/0008-5472.CAN-07-1649","article-title":"Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane","volume":"67","author":"Lyu","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2019.101394_bib65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/clpt.2013.201","article-title":"Topoisomerase 2beta: a promising molecular target for primary prevention of anthracycline-induced cardiotoxicity","volume":"95","author":"Vejpongsa","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.redox.2019.101394_bib66","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1111\/jcmm.14346","article-title":"Doxorubicin-induced cardiotoxicity is maturation dependent due to the shift from topoisomerase IIalpha to IIbeta in human stem cell derived cardiomyocytes","volume":"23","author":"Cui","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.redox.2019.101394_bib67","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/heartjnl-2017-312103","article-title":"Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention","volume":"104","author":"Henriksen","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.redox.2019.101394_bib68","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/carcin\/bgr031","article-title":"The multiple roles of autophagy in cancer","volume":"32","author":"Rosenfeldt","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.redox.2019.101394_bib69","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/S0140-6736(16)31797-4","article-title":"2016 Nobel prize in medicine goes to Japanese scientist","volume":"388","author":"Mohammadi","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2019.101394_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bj.2017.03.001","article-title":"Food for thought: autophagy researcher wins 2016 Nobel prize in physiology or medicine","volume":"40","author":"Walton","year":"2017","journal-title":"Biomed. J."},{"key":"10.1016\/j.redox.2019.101394_bib71","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1101\/gad.287524.116","article-title":"Recent insights into the function of autophagy in cancer","volume":"30","author":"Amaravadi","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.redox.2019.101394_bib72","doi-asserted-by":"crossref","first-page":"46663","DOI":"10.18632\/oncotarget.16944","article-title":"Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity","volume":"8","author":"Koleini","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.redox.2019.101394_bib73","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1161\/CIRCULATIONAHA.115.017443","article-title":"Doxorubicin blocks cardiomyocyte autophagic flux by inhibiting lysosome acidification","volume":"133","author":"Li","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2019.101394_bib74","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/s41598-018-37862-3","article-title":"Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration","volume":"9","author":"Abdullah","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2019.101394_bib75","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11748-012-0131-2","article-title":"Transaortic edge-to-edge mitral valve repair and left ventricular myectomy","volume":"61","author":"Tsutsumi","year":"2013","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.redox.2019.101394_bib76","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4161\/auto.8.1.18536","article-title":"TOR-autophagy signaling in adult zebrafish models of cardiomyopathy","volume":"8","author":"Ding","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2019.101394_bib77","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.freeradbiomed.2014.06.011","article-title":"Calorie restriction combined with resveratrol induces autophagy and protects 26-month-old rat hearts from doxorubicin-induced toxicity","volume":"74","author":"Dutta","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101394_bib78","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tox.2016.09.011","article-title":"Basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity","volume":"370","author":"Pizarro","year":"2016","journal-title":"Toxicology"},{"key":"10.1016\/j.redox.2019.101394_bib79","doi-asserted-by":"crossref","first-page":"11989","DOI":"10.1038\/s41598-017-12095-y","article-title":"Honokiol protects against doxorubicin cardiotoxicity via improving mitochondrial function in mouse hearts","volume":"7","author":"Huang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2019.101394_bib80","doi-asserted-by":"crossref","first-page":"29","DOI":"10.21775\/cimb.028.029","article-title":"PGC-1: the energetic regulator in cardiac metabolism","volume":"28","author":"Di","year":"2018","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.redox.2019.101394_bib81","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1242\/jcs.113662","article-title":"PGC1alpha and mitochondrial metabolism--emerging concepts and relevance in ageing and neurodegenerative disorders","volume":"125","author":"Austin","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.redox.2019.101394_bib82","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/cvr\/cvn098","article-title":"Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha","volume":"79","author":"Ventura-Clapier","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.redox.2019.101394_bib83","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/cvr\/cvy155","article-title":"Heart specific PGC-1alpha deletion identifies metabolome of cardiac restricted metabolic heart failure","volume":"115","author":"Karkkainen","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.redox.2019.101394_bib84","first-page":"339","article-title":"Oxidative metabolism in cancer growth","volume":"9","author":"Ristow","year":"2006","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.redox.2019.101394_bib85","doi-asserted-by":"crossref","first-page":"917606","DOI":"10.1155\/2015\/917606","article-title":"Exercise prevention of cardiovascular disease in breast cancer survivors","volume":"2015","author":"Kirkham","year":"2015","journal-title":"J Oncol"},{"key":"10.1016\/j.redox.2019.101394_bib86","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/biof.1385","article-title":"Neuroprotective effects of honokiol: from chemistry to medicine","volume":"43","author":"Talarek","year":"2017","journal-title":"Biofactors"},{"key":"10.1016\/j.redox.2019.101394_bib87","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4049\/jimmunol.179.2.753","article-title":"Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis","volume":"179","author":"Munroe","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.redox.2019.101394_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092757","article-title":"Effects of polyphenols on thermogenesis and mitochondrial biogenesis","volume":"19","author":"Wood Dos Santos","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2019.101394_bib89","doi-asserted-by":"crossref","first-page":"34082","DOI":"10.18632\/oncotarget.16133","article-title":"Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice","volume":"8","author":"Pillai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.redox.2019.101394_bib90","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1038\/ncomms7656","article-title":"Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3","volume":"6","author":"Pillai","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2019.101394_bib91","first-page":"3360","article-title":"Sirt3 attenuates doxorubicin-induced cardiac hypertrophy and mitochondrial dysfunction via suppression of Bnip3","volume":"9","author":"Du","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.redox.2019.101394_bib92","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3945\/jn.109.113415","article-title":"Oral glutamine protects against acute doxorubicin-induced cardiotoxicity of tumor-bearing rats","volume":"140","author":"Todorova","year":"2010","journal-title":"J. Nutr."},{"key":"10.1016\/j.redox.2019.101394_bib93","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0148607115581838","article-title":"Nutrition modulation of cardiotoxicity and anticancer efficacy related to doxorubicin chemotherapy by glutamine and omega-3 polyunsaturated fatty acids","volume":"40","author":"Xue","year":"2016","journal-title":"JPEN - J. Parenter. Enter. Nutr."},{"key":"10.1016\/j.redox.2019.101394_bib94","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/jsre.1999.5677","article-title":"Glutamine protects against doxorubicin-induced cardiotoxicity","volume":"85","author":"Cao","year":"1999","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.redox.2019.101394_bib95","doi-asserted-by":"crossref","first-page":"41637","DOI":"10.18632\/oncotarget.9317","article-title":"Altered glutamine metabolism in platinum resistant ovarian cancer","volume":"7","author":"Hudson","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.redox.2019.101394_bib96","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1715971","article-title":"A phase 3 trial of l-glutamine in sickle cell disease","volume":"379","author":"Niihara","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2019.101394_bib97","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1021\/acs.biochem.7b00785","article-title":"A new step in the treatment of sickle cell DiseasePublished as part of the biochemistry series \"biochemistry to bedside","volume":"57","author":"Ortiz de Montellano","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.redox.2019.101394_bib98","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1515\/hsz-2016-0316","article-title":"The role of sirtuins in mitochondrial function and doxorubicin-induced cardiac dysfunction","volume":"398","author":"Dolinsky","year":"2017","journal-title":"Biol. Chem."},{"key":"10.1016\/j.redox.2019.101394_bib99","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/j.bbadis.2017.07.030","article-title":"Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts","volume":"1863","author":"Coelho","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.redox.2019.101394_bib100","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1161\/CIRCRESAHA.119.313577","article-title":"Anthracycline and peripartum cardiomyopathies","volume":"124","author":"Cowgill","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2019.101394_bib101","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.chembiol.2012.08.011","article-title":"Bacterial inactivation of the anticancer drug doxorubicin","volume":"19","author":"Westman","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.redox.2019.101394_bib102","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3389\/fmicb.2019.01050","article-title":"Gut microbiota shapes the efficiency of cancer therapy","volume":"10","author":"Ma","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.redox.2019.101394_bib103","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/ejhf.1172","article-title":"Anthracycline-induced cardiomyopathy: secrets and lies","volume":"20","author":"Farmakis","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.redox.2019.101394_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15563650.2018.1497172","article-title":"Mechanisms of toxic cardiomyopathy","volume":"57","author":"Hantson","year":"2019","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.redox.2019.101394_bib105","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/CIRCULATIONAHA.115.010484","article-title":"Cardio-oncology: how new targeted cancer therapies and precision medicine can inform cardiovascular discovery","volume":"132","author":"Bellinger","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2019.101394_bib106","doi-asserted-by":"crossref","first-page":"140","DOI":"10.15420\/cfr.2017:16:1","article-title":"The future role of cardio-oncologists","volume":"3","author":"Pudil","year":"2017","journal-title":"Card. Fail. Rev."},{"key":"10.1016\/j.redox.2019.101394_bib107","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jacc.2014.06.1167","article-title":"Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities","volume":"64","author":"Vejpongsa","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.redox.2019.101394_bib108","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.115.303633","article-title":"Cardio-oncology: an update on cardiotoxicity of cancer-related treatment","volume":"118","author":"Lenneman","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2019.101394_bib109","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11906-010-0146-y","article-title":"Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage","volume":"12","author":"Geisberg","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.redox.2019.101394_bib110","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/S1470-2045(17)30535-1","article-title":"Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?","volume":"18","author":"Levis","year":"2017","journal-title":"Lancet Oncol."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231719312637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231719312637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:12:17Z","timestamp":1761977537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231719312637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":110,"alternative-id":["S2213231719312637"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2019.101394","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree?","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2019.101394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101394"}}